New stent aims to prevent stroke in patients with clogged brain arteries

NCT ID NCT07352852

Recruiting now Disease control Sponsor: The Affiliated Hospital of Qingdao University Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study is testing a special stent coated with the drug rapamycin to treat narrowed brain arteries in people who haven't gotten better with medication alone. About 300 participants will receive the stent and be monitored for up to a year to see if it reduces the risk of stroke or death. The trial also checks for re-narrowing of the artery and overall safety.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: rapamycin-eluting stent
What this could lead to: If successful, this could provide a better treatment option for people with narrowed brain arteries who haven't improved with medication, potentially reducing their risk of stroke.
What could go wrong: This is a single-arm study without a comparison group, so results may be less definitive. The stent procedure itself carries risks like stroke or death, and long-term benefits beyond 1 year are not yet known.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BRAIN DISEASES are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

brain disorder cerebral artery stenosis intracranial arterial disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

BRAIN DISEASES INTRACRANIAL ARTERIAL STENOSIS

Contacts and locations

Locations

Qingdao University Affiliated Hospital
RECRUITING

Qingdao, Shandong, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.